Re: iPSC patents headed for a showdown?
MEMBERS' OPEN FORUM: for rapid-fire posting of your questions and comments.
James Beck, PDF
17 Feb 2010
Commercially, it seems there are two possible outcomes once the paper patent to be issued to Jaenisch is reviewed by the IP experts: the patent will be licensed (an apparent business goal of Fate) or ... 
iPSC patents headed for a showdown?
MEMBERS' OPEN FORUM: for rapid-fire posting of your questions and comments.
Brian K. Fiske, MJFF
10 Feb 2010
A recent blog over at ScienceInsider (Landmark Pluripotent Patent Has Stem Cell Researchers Nervous) discusses the recent awarding of a patent to MIT researcher Rudolph Jaenisch and MGH researcher ... 
Responses: 1
When should you publish in the patent process?
4th Drug Discovery for Neurodegeneration
Holli Kawadler, MJFF
02 Feb 2010
It usually takes about 5 years for a patent to come through from start to finish. A frequently misunderstood question in the academic world is, "When can you publish and still protect your patent ... 
Medicinal chemistry - when do you need to start considering IP?
4th Drug Discovery for Neurodegeneration
Holli Kawadler, MJFF
01 Feb 2010
From the chemist point of view, how soon should you start considering IP when identifying small molecules from a high throughput screen? ... 
What is IP and how do you get it? - Q&A with Dr. Brian Laden
The Business of Science
Brian Laden, Vanderbilt, et al.
02 Nov 2009
Investigators are often encouraged to publish their scientific results as quickly as possible, not only for career prestige, but also to ensure future funding remains possible.  Unfortunately, ... 
Summary of the scientific session at Udall 2009
Hot Topics@Udall 2009
James P Bennett Jr, VCU
24 Sep 2009
The scientific session of the 11th Annual Morris Udall Parkinson’s Center Conference had four speakers.  ... 
Discussion at Udall 2009: The Therapeutic Pipeline
Hot Topics@Udall 2009
Holli Kawadler, MJFF
22 Sep 2009
Dr. James Bennett began this morning's discussion speaking about the translational "Valley of Death", that time between pre-IND research to the end of Phase 1 trials when most clinical therapeutic ... 
A step in the right direction for tool sharing....
What are the benefits to sharing a pre-clinical research model, other than scientific collaboration?
Darren J Moore, EPFL
16 Jul 2009
Yes, Mark, I fully agree. This is an issue for anyone who creates a mouse model and provides an ongoing debate. I think it is fair to say that while repositories now provide a well-developed ... 
Recent Nature correspondence on tool sharing
What are the benefits to sharing a pre-clinical research model, other than scientific collaboration?
Mark Cookson, NIH
15 Jul 2009
A recent Nature correspondence on the subject of mouse sharing raises some concerns about sharing.  Obviously, this is an ongoing discussion in many areas of science, not just in ... 
Responses: 1
Reply to "Tool Sharing: Get On It"
What are the benefits to sharing a pre-clinical research model, other than scientific collaboration?
Darren J Moore, EPFL
14 Jul 2009
I would like to second the comments made by Mike Sasner. We recently donated a new collection of conditional mutant alpha-synuclein transgenic mice (JAX Stock # 008883, 008886, 008889), to JAX labs ... 
Responses: 2